EP3274352

HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.3.2016
  • EP published:
    2.1.2019
  • EP application number:
    16710764.8
  • Max expiry date:
    20.3.2036
  • Title:
    HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR

Timeline

Today
21.3.2016EP application
2.1.2019EP Publication

Owner

  • Name:
    Bayer Pharma Aktiengesellschaft
  • Address:
    Müllerstrasse 178, 13353, Berlin, DE

Inventor

  • Name:
    HÄRTER, Michael
  • Address:
    Leverkusen, DE
  • Name:
    KOSEMUND, Dirk
  • Address:
    Berlin, DE
  • Name:
    DELBECK, Martina
  • Address:
    Heiligenhaus, DE
  • Name:
    KALTHOF, Bernd
  • Address:
    Wuppertal, DE
  • Name:
    WASNAIRE, Pierre
  • Address:
    Düsseldorf, DE
  • Name:
    SÜSSMEIER, Frank
  • Address:
    München, DE
  • Name:
    LUSTIG, Klemens
  • Address:
    Wuppertal, DE

Priority

  • Number:
    15161165
  • Date:
    26.3.2015
  • Country:
    EP
  • Number:
    15174566
  • Date:
    30.6.2015
  • Country:
    EP
  • Number:
    15184732
  • Date:
    10.9.2015
  • Country:
    EP

Classification

  • Categories:
    C07D 495/04, A61K 31/519, A61P 37/00, A61P 35/00, A61P 11/00

Upload documents